References
- Aronin PA, Mahaley MS Jr, Rudnick SA, . Prediction of BCNU pulmonary toxicity in patients with malignant gliomas: an assessment of risk factors. N Engl J Med 1980;303:183–188.
- Ager S, Mahendra P, Richards EM, . High-dose carmustine, etoposide and melphalan (“BEM”) with autologous stem cell transplantation: a dose-toxicity study. Bone Marrow Transplant 1996; 17:335–340.
- Takvorian T, Parker LM, Hochberg FH, . Autologous bone-marrow transplantation: host effects of high-dose BCNU. J Clin Oncol 1983;1:610–620.
- Weaver CH, Appelbaum FR, Petersen FB, . High-dose cyclophosphamide, carmustine, and etoposide followed by autologous bone marrow transplantation in patients with lymphoid malignancies who have received dose-limiting radiation therapy. J Clin Oncol 1993;11:1329–1335.
- Lane AA, Armand P, Feng Y, . Risk factors for development of pneumonitis after high-dose chemotherapy with cyclophosphamide, BCNU and etoposide followed by autologous stem cell transplant. Leuk Lymphoma 2012;53:1130–1136.
- Panoskaltsis-Mortari A, Griese M, Madtes DK, . An official American Thoracic Society research statement: noninfectious lung injury after hematopoietic stem cell transplantation: idiopathic pneumonia syndrome. Am J Respir Crit Care Med 2011;183:1262–1279.
- Litam JP, Dail DH, Spitzer G, . Early pulmonary toxicity after administration of high-dose BCNU. Cancer Treat Rep 1981;65:39–44.
- Rossi SE, Erasmus JJ, McAdams HP, . Pulmonary drug toxicity: radiologic and pathologic manifestations. Radiographics 2000;20: 1245–1259.
- Wilczynski SW, Erasmus JJ, Petros WP, . Delayed pulmonary toxicity syndrome following high-dose chemotherapy and bone marrow transplantation for breast cancer. Am J Respir Crit Care Med 1998;157:565–573.
- Alessandrino EP, Bernasconi P, Colombo A, . Pulmonary toxicity following carmustine-based preparative regimens and autologous peripheral blood progenitor cell transplantation in hematological malignancies. Bone Marrow Transplant 2000;25:309–313.
- Rubio C, Hill ME, Milan S, . Idiopathic pneumonia syndrome after high-dose chemotherapy for relapsed Hodgkin's disease. Br J Cancer 1997;75:1044–1048.